• Order to parcel locker

    Order to parcel locker
  • easy pay

    easy pay
  • Reduced price
Antibiotic Drug Discovery: New Targets and Molecular Entities

Antibiotic Drug Discovery: New Targets and Molecular Entities

9781782624240
1,064.70 zł
958.23 zł Save 106.47 zł Tax included
Lowest price within 30 days before promotion: 958.23 zł
Quantity
Available in 4-6 weeks

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
Recent years have seen a resurgence of antibiotic drug discovery. This book brings together the relevant information to assess the state-of-the-art. It identifies and elaborates the most recent and compelling strategies for antibiotic drug discovery with a primary focus on new targets, mechanisms and molecular entities. Addressing the need for continued investment in antibiotic drug development, the book provides a point of reference for the rapidly expanding infectious disease research community. In addition to its attention on new targets, the book focusses on the medicinal chemistry and chemistry of the targets. Within this framework, chapters from leading researchers in academia and industry address findings in important areas such as biofilm production, narrow spectrum antibiotics and novel antibacterials from previously uncultured soil bacteria. This book will be a useful resource for postgraduate students and researchers in medicinal chemistry wishing to understand the latest approaches to antibiotic drug discovery.
Product Details
77382
9781782624240
9781782624240

Data sheet

Publication date
2017
Issue number
1
Cover
hard cover
Pages count
286
Dimensions (mm)
156.00 x 234.00
Weight (g)
582
  • Treatment of Clostridium difficile Infections; Targeting Purine Biosynthesis for Antibacterial Drug Design; Inhibitors of Biofilm Production; Narrow Spectrum Antibacterial Agents; The LPS Transport Pathway:: A New Target for the Development of Gram-Negative Antibiotics; The Discovery of Teixobactin; Emerging Targets in Anti-Tubercular Drug Design; Antibacterial Leads Targeting Isoprenoid Biosynthesis
Comments (0)